Australia - English - Department of Health (Therapeutic Goods Administration)

vitality brands worldwide pty ltd - zinc oxide, quantity: 50 mg/g; 4-methylbenzylidene camphor, quantity: 10 mg/g; bemotrizinol, quantity: 25 mg/g; methylene bis-benzotriazolyl tetramethylbutylphenol, quantity: 25 mg/g - lotion - excipient ingredients: aloe vera; caprylyl glycol; 1,2-hexanediol; dl-alpha-tocopheryl acetate; phenoxyethanol; purified water; alkyl (c12-15) benzoate; isopropyl palmitate; propylene glycol; xanthan gum; decyl glucoside; disodium edetate; carnauba wax; butylated hydroxytoluene; triacontanyl pvp; peg-30 dipolyhydroxystearate; calcium stearate; magnesium sulfate heptahydrate; glyceryl monooleate - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 plus broad spectrum very high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Canada - English - Health Canada

sanis health inc - propafenone hydrochloride - tablet - 150mg - propafenone hydrochloride 150mg - class ic antiarrythmics

Canada - English - Health Canada

sanis health inc - propafenone hydrochloride - tablet - 300mg - propafenone hydrochloride 300mg - class ic antiarrythmics

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - propafenone hydrochloride (unii: 33xch0hocd) (propafenone - unii:68iqx3t69u) - propafenone hydrochloride 150 mg - in patients without structural heart disease, propafenone is indicated to prolong the time to recurrence of as with other agents, some patients with atrial flutter treated with propafenone have developed 1:1 conduction, producing an increase in ventricular rate. concomitant treatment with drugs that increase the functional av refractory period is recommended. the use of propafenone hcl in patients with chronic atrial fibrillation has not been evaluated. propafenone hcl should not be used to control ventricular rate during atrial fibrillation. propafenone hcl is also indicated for the treatment of initiation of propafenone hcl treatment, as with other antiarrhythmics used to treat life-threatening ventricular arrhythmias, should be carried out in the hospital. propafenone hcl, like other antiarrhythmic drugs, has not been shown to enhance survival in patients with ventricular or atrial arrhythmias. propafenone hcl is contraindicated in the presence of uncontrolled congestive heart failure, cardiogenic shock, s

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - propafenone hydrochloride (unii: 33xch0hocd) (propafenone - unii:68iqx3t69u) - propafenone hydrochloride 150 mg - in patients without structural heart disease, propafenone hcl is indicated to prolong the time to recurrence of - –paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms. - –paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms. as with other agents, some patients with atrial flutter treated with propafenone have developed 1:1 conduction, producing an increase in ventricular rate. concomitant treatment with drugs that increase the functional av refractory period is recommended. the use of propafenone hcl in patients with chronic atrial fibrillation has not been evaluated. propafenone hcl should not be used to control ventricular rate during atrial fibrillation. propafenone hcl is also indicated for the treatment of - –documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. because of the proarrhythmic effects of propafenone hcl, its use with lesser ventricular arrhythmias

United States - English - NLM (National Library of Medicine)

aromatica co. - zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - zinc cation 2.7 g in 15 g

United States - English - NLM (National Library of Medicine)

aromatica co. - zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - zinc cation 0.18 in 50 g

United States - English - NLM (National Library of Medicine)

aromatica co. - zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - zinc cation 0.18 in 50 g

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - propafenone hydrochloride - oral tablet - 150mg

Ireland - English - HPRA (Health Products Regulatory Authority)

evolan pharma ab - zinc oxide - impregnated dressing - . percent volume/volume - zinc bandages; zinc bandage without supplements